Education
About Us
Working with TipRanks
Follow Us
IDEAYA Biosciences (IDYA)
NASDAQ:IDYA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 7.00M | $ 23.39M | $ 50.93M | $ 27.94M | $ 19.54M |
| Gross Profit | $ 3.17M | $ 19.38M | $ 48.83M | $ 26.22M | $ 18.16M |
| Operating Income | $ -326.98M | $ -134.43M | $ -62.50M | $ -50.27M | $ -35.34M |
| EBITDA | $ -270.64M | $ -108.95M | $ -56.55M | $ -48.04M | $ -33.11M |
| Net Income | $ -274.48M | $ -112.96M | $ -58.66M | $ -49.76M | $ -34.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 676.32M | $ 525.11M | $ 364.83M | $ 246.77M | $ 283.58M |
| Total Assets | $ 1.12B | $ 649.32M | $ 387.97M | $ 381.35M | $ 298.27M |
| Total Debt | $ 19.17M | $ 2.87M | $ 3.48M | $ 5.18M | $ 6.72M |
| Net Debt | $ -65.21M | $ -154.15M | $ -65.15M | $ -86.86M | $ -65.31M |
| Total Liabilities | $ 64.94M | $ 28.23M | $ 38.51M | $ 79.83M | $ 100.00M |
| Stockholders' Equity | $ 1.06B | $ 621.09M | $ 349.45M | $ 301.51M | $ 198.27M |
| Cash Flow | |||||
| Free Cash Flow | $ -251.44M | $ -117.59M | $ -90.62M | $ -58.42M | $ 54.97M |
| Operating Cash Flow | $ -247.58M | $ -115.22M | $ -87.17M | $ -55.78M | $ 55.46M |
| Investing Cash Flow | $ -502.56M | $ -158.46M | $ -33.40M | $ -69.67M | $ -146.24M |
| Financing Cash Flow | $ 677.55M | $ 362.72M | $ 97.17M | $ 145.45M | $ 128.75M |